Metzger Michael A's Form 4 filing
Cti Biopharma Corp (CTIC) · filed Jul 11, 2022
- Accession no.
- 0000891293-22-000036
- Filed
- Jul 11, 2022
- Trade date
- Jul 7, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $131.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Metzger Michael ACIK 0001507220 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2022 | common stock | SSaleDisposed | −9,000 | $6.50 | −$58,500 | 11,121 | Direct | |
| Jul 7, 2022 | common stock | SSaleDisposed | −5,900 | $6.51 | −$38,409 | 5,221 | Direct | |
| Jul 7, 2022 | common stock | SSaleDisposed | −3,321 | $6.52 | −$21,652.92 | 1,900 | Direct | |
| Jul 7, 2022 | common stock | SSaleDisposed | −400 | $6.53 | −$2,612 | 1,500 | Direct | |
| Jul 7, 2022 | common stock | SSaleDisposed | −400 | $6.54 | −$2,616 | 1,100 | Direct | |
| Jul 7, 2022 | common stock | SSaleDisposed | −1,100 | $6.55 | −$7,205 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.